Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Aug 20, 2019 2:52pm

98 Views

Post# 30047672

RE:RE:RE:RE:Another Prospectus Nugget

Just the thought that doing it this way will give continuous flow of treated patients. Should something go amiss there is enough time to adjust although it would appear unlikely. This also can cause for better upward momentum in the share price .. on the final note better with this timeframe as getting done earlier will be met with cheers.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario